Temporal influence of endocrine therapy with tamoxifen and chemotherapy on nutritional risk and obesity in breast cancer patients

Table 3 Model effect tests of tamoxifen use duration groups and whether or not chemotherapy is performed

Variable	Effect	df	Wald Chi-square	*p-value
BMI	Duration of use	2	3.16	0.206
	CT	1	2.68	0.102
	Duration of use x CT	2	12.31	0.002
WC	Duration of use	2	11.88	0.003
	CT	1	2.99	0.084
	Duration of use x CT	2	22.27	0.000
BFP	Duration of use	2	14.29	0.001
	CT	1	0.27	0.607
	Duration of use x CT	2	37.95	0.000

BMI, Body Mass Index; WC, waist circumference; BFP, body fat percentage; CT, chemotherapy; General Estimated Equations (GEE). Data adjusted for age, smoking, alcohol consumption, physical activity, energy (kcal), and clinical stage. df, Degree of freedom
*p values calculated by ANOVA

ISSN: 1471-2407